Both in Pharmaceuticals
Pyxis Oncology vs MacroGenics
Over the past year PYXS returned +31.8% and MGNX returned +115.4%; their daily moves had a correlation of 0.15.
PYXS +31.8% MGNX +115.4%Growth of $1, one year, split-adjusted
| Metric | PYXS | MGNX |
|---|---|---|
| Price | $2.90 | $3.77 |
| Market cap | $241.9M | $240.1M |
| Today | 0.00% | −7.14% |
| 1 month | −10.2% | −8.7% |
| 6 months | +128.3% | +36.6% |
| Year to date | +152.2% | +134.2% |
| 1 year | +35.5% | +117.9% |
| Revenue growth (YoY) | −100.0% | +378.0% |
| Gross margin | — | 100.0% |
| Net margin | — | 59.4% |
| P/E (TTM) | — | — |
| Price / sales | 21.9× | 1.4× |
| Net cash | $33.0M | $173.3M |
| Dividend yield | — | — |
| Volatility (60d) | 128.4% | 62.8% |
| Short % of float | 12.9% | 11.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).